The Company conducts its business in various foreign countries, and as such, its cash flows and earnings are subject to fluctuations from changes in foreign currency exchange rates. The Company sells products from its domestic operations to its foreign subsidiaries, creating additional currency risk. The Company manages its exposures to this market risk through internally established procedures and, when deemed appropriate, through the use of short-term forward exchange contracts which were not significant as of May 31, 2026. The Company does not enter into derivative transactions or use other financial instruments for trading or speculative purposes. The Company is subject to the risk that market interest rates and its cost of borrowing will increase and thereby increase the interest charged under its variable-rate debt. Additional information relating to the Company’s derivative transactions and outstanding financial instruments is included in Note 21, "Derivatives and Hedging," and Note 6, "Debt," respectively, of Notes to Consolidated Financial Statements in Item 8, “Consolidated Financial Statements and Supplementary Data,” which is included herein. 35 The following table sets forth information about the Company’s debt instruments as of May 31, 2026: $ amounts in millions Fiscal Year Maturity Fair Value 2027 2028 2029 2030 2031 Thereafter Total 2026 Debt Obligations Lines of credit and current portion of long-term debt $ 5.5 $ — $ — $ — $ — $ — $ 5.5 $ 5.5 Average interest rate 4.2 % — — — — — Long-term debt $ — $ — $ — $ 75.0 $ — $ — $ 75.0 $ 75.0 Average interest rate — — — 5.2 % — — Film related obligations (1) $ 2.6 $ 6.3 $ 8.1 $ 0.1 $ — $ — $ 17.1 $ 17.1 Average interest rate 5.8 % 5.1 % 5.0 % 5.0 % — — (1) Film related obligations are due on demand. Outstanding borrowings are presented by fiscal year maturity based on expected repayment dates per loan agreements. 36